Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.



How to Profit from Compound Management Know-How?

Posted: 09/14/2011

Oliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview Peter covers biosample stabilisation, optimum data structures to store biosample information, challenges associated with low temperature storage and how to profit from compound management know-how.

To View Full Video Content, Please Join Now:
To continue viewing this content please fill out the form below and become an IQ member.
Or if you're already a Pharma IQ member, sign in to download.

First Name*
Last Name*
Job Title*
Company*
Country
State
E-mail*
Username*
Password*
Confirm Password*

By clicking Submit, you accept our User Agreement, Privacy Policy, and Cookie Policy.
Tags:  Oliver Peter | drug discovery | HTS | biosample stabilisation | optimum data structures | compound management | biosamples | materials management | biobanking | Actelion Pharmaceuticals

This interview was conducted at IQPC's 8th Compound Management & Integrity event in May 2011.

Have Your Say
Rate this feature and give us your feedback in the comments section below


comments powered by Disqus


Advertise With Us

Join the Pharmas IQ Community